Skip to main content
. 2018 Dec 17;19(12):4081. doi: 10.3390/ijms19124081

Table 1.

New candidate molecules for novel targets in pulmonary hypertension.

New Candidate Molecules Novel Targets References
Fasudil Rho-kinase (human, inharation) [134]
Fasudil Rho-kinase (human, oral) [72]
Fasudil Rho-kinase (rodents) [37]
Metformin AMPK (mouse) [25]
PPARα agonist (Fenofibrate, WY14643) TAFI (mouse) [126]
TAFIa inhibitor (carboxypeptidase inhibitor) TAFI (mouse) [126]
Sanguinarin Selenoprotein P (rat) [107]
Celastrol Cyclophilin A and Basigin (mouse) [85]